Green and black teas inhibit atherosclerosis by lipid, antioxidant, and fibrinolytic mechanisms

Journal of Agricultural and Food Chemistry

Volumn 52, Issue 11, 2004, Pages 3661-3665

  Vinson, Joe A ^a   Teufel, Karolyn ^a   Wu, Nancy ^a  

^a UNIVERSITY OF SCRANTON   (United States)

Author keywords

Atherosclerosis; Black tea; Fibrinogen; Green tea; Hamster; Lipid peroxidation; Lipids

Indexed keywords

ANTIOXIDANT; BLACK TEA EXTRACT; FIBRINOGEN; FIBRINOLYTIC AGENT; GREEN TEA EXTRACT; HIGH DENSITY LIPOPROTEIN; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; EPIDEMIOLOGICAL DATA; HAMSTER; HEART DISEASE; INCIDENCE; LOW DRUG DOSE; MALE; NONHUMAN; PATHOGENESIS; TEA; TREATMENT OUTCOME;

ANIMALS; ANTIOXIDANTS; ARTERIOSCLEROSIS; CRICETINAE; DISEASE MODELS, ANIMAL; FIBRINOLYSIS; LIPID PEROXIDATION; LIPIDS; MALE; MESOCRICETUS; TEA;

ANIMALIA; CAMELLIA SINENSIS; CRICETINAE;

EID: 2542456005     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf035255l     Document Type: Article

References (33)

1. Balentine, D. A.; Manufacturing and Chemistry of Tea. In Phenolic Compounds in Food and Their Effects on Health 1; Ho, C. T., Lee, C. Y., Huang, M. T., Eds.; American Chemical Society: Washington, DC, 1992; pp 103-107.
2. Hollman, P. C. H.; Feskens, E. J. M.; Katan, M. B. Tea flavonols in cardiovascular diseaseand cancer epidemiology. Proc. Soc. Exp. Biol. Med. 1999, 22, 198-202.
3. Peters, U.; Poole, C.; Arab, L. Does tea affect cardiovascular disease? A meta-analysis. Am. J. Epidemiol. 2001, 15, 495-503.
4. Stensvold, I.; Tverdal, A.; Solvoll, K.; Foss, K. P. Tea consumption. Relationship to cholesterol, blood pressure, and coronary and total mortality. Prev. Med. 1992, 21, 546-563.
5. Tsubono, Y.; Tsugane, S. Green tea intake in relation to serum lipid levels in middle age Japanese men and women. Ann. Epidemiol. 1997, 7, 280-284.
6. Bingham, S. A.; Vorster, H.; Jerling, J. C.; Magee, E.; Mulligan, A.; Runswick, S. A. Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. Br. J. Nutr. 1997, 78, 41-55.
7. van het Hof, K. H.; DeBoer, H. S.; Wiseman, S. A.; Lien, N.; Westrate, J. A.; Tijburg, L. B. Consumption of green or black tea does not increase resistance of low-density lipoprotein oxidation in humans. Am. J. Clin. Nutr. 1997, 66, 1125-1132.
8. Serafini, M.; Ghiselli, A.; Ferro-Luzzi, A. In vivo antioxidant effect of green and black tea in man. Eur. J. Clin. Nutr. 1996, 50, 79-85.
9. Leenan, R.; Roodenburg, A. J.; Tijburg, L.; Wiseman, S. A single dose of tea with orwithout milk increases plasma antioxidant capacity in humans. Eur. J. Clin. Nutr. 2000, 54, 87-92.
10. Ishikawa, T.; Suzukawa, M.; Ito, T.; Yoshida, H.; Ayaori, M.; Nishiwaki, M.; Yonemura, A. Effect of tea flavonoid supplementation on the susceptibility of low-densitylipoprotein to oxidative modification. Am. J. Clin. Nutr. 1997, 66, 261-266.
11. Matsumoto, N.; Okushio, K.; Hara, Y. Effect of black tea on plasma lipids in cholesterol-fed rats. J. Nutr. Sci Vitaminol. 1998, 44, 337-342.
12. Muramatu, K.; Fukuyo, M.; Hara, Y. Effect of green tea catechins on plasma cholesterol in cholesterol-fed rats. J. Nutr. Sci. Vitaminol. 1986, 32, 613-622.
13. Tijburg, L. B. M.; Wiseman, S. A.; Meijer, G. W.; Westrate, J. A. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolemic rabbits. Atherosclerosis 1997, 135, 37-47.
14. Young, W.; Hotovec, R. L.; Romero, A. G. Tea and atherosclerosis. Nature 1967, 216, 1015-1016.
15. Miura, Y.; Chiba, T.; Tomita, I.; Koizumi, H.; Miura, S.; Umegaki, K.; Hara, Y.; Ikeda, M.; Tomita, T. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J. Nutr. 2001, 131, 27-32.
16. Vinson, J. A.; Dabbagh, Y. A. Effect of green and black tea supplementation on lipids,lipid oxidation and fibrinogen in the hamster: mechanisms for the epidemiological benefits of tea drinking. FEBS Lett. 1998, 433, 44-46.
17. Pan, T.; Jankovic, J.; Le, W. Potential therapeutic properties of green tea polyphenols in Parkinson's disease. Drugs Aging 2003, 20, 711-721.
18. Vinson, J. A.; Dabbagh, Y. A. Tea phenols: antioxidant effectiveness of teas, tea components, tea fractions and their binding with lipoproteins. Nutr. Res. 1998, 18, 1067-1075.
19. Rice-Evans, C. A.; Miller, N. J. Antioxidant activities of flavonoids as bioactive components of food. Biochem. Soc. Trans. 1996, 24, 790-794.
20. Vinson, J. A.; Teufel, K.; Wu, N. Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model. Atherosclerosis 2000, 156, 67-72.
21. Vinson, J. A.; Hu, S.-J.; Jung, S.; Stanski, A. A citrus extract plus ascorbic acid decreases lipids, lipid peroxides, lipoprotein oxidative susceptibility, and atherosclerosis in hypercholesterolemic hamsters. J. Agric. Food Chem. 1998, 46, 1453-1459.
22. Wang Z. Y.; Huang, M. T.; Lou, Y. R.; Xie, J. G.; Reuhl, K. R.; Newmark, H. L.; Ho, C. T.; Yang, C. S.; Conney, A. H. Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice. Cancer Res. 1994, 54, 3428-3435.
23. Chisolm, G. M.; Steinberg, D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radical Biol. Med. 2000, 28, 1815-1826.
24. Raederstorff, D. G.; Schachter, M. F.; Elste, V.; Weber, P. Effect of EGCG on lipid absorption and plasma lipid levels in rats. J. Nutr. Biochem. 2003, 14, 326-332.
25. Matsumoto, N.; Okushio, K.; Hara, Y. Effect of black tea polyphenols on plasma lipids in cholesterol-fed rats. J. Nutr. Sci. Vitaminol. 1998, 44, 337-342.
26. Bursill, C.; Roach, P. D.; Bottema, C. D.; Pal, S. Green tea upregulates the low-density lipoprotein receptor through the sterol-regulated element binding protein in HepG2 liver cells. J. Agric. Food Chem. 2001, 49, 5639-5645.
27. Koenig, W. Fibrin(ogen) in cardiovascular disease: an update. Thromb. Haemostasis 2003, 89, 601-609.
28. Sasazuki, S.; Kodama, H.; Yoshimasu, K.; Liu, Y.; Washio, M.; Tanaka, K. ; Tokunaga, S.; Kono, S.; Arai, H.; Doi, Y.; Kawano, T.; Nakagaki, O.; Takada, K.; Koyanagi, S.; Hiyamuta, K.; Nii, T.; Shirai, K.; Ideishi, M.; Arakawa, K.; Mohri, M.; Takeshita, A. Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann. Epidemiol. 2000, 10, 401-408.
29. Tokunaga, S.; White, I. R.; Frost, C.; Tanaka, K.; Kono, S.; Tokudome, S.; Akamatsu, T.; Moriyama, T.; Zakouji, H. Green tea consumption and serum lipids and lipoproteinsin a Population of healthy workers in Japan. Ann. Epidemiol. 2000, 12, 157-165.
30. Moon, Y. K.; Back, S.; Shin, D.; Yang, J. L. Effects of green tea consumption on serum lipid profiles. FASEB J. 2002, 16, abstract 489.3.
31. Maron, D. J.; Lu, G. P.; Cai, N. S.; Wu, Z. G.; Li, Y. H.; Chen, H.; Zhu, J. Q.; Jin, X. J.; Wouters, B. C.; Zhao, J. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch. Int. Med. 2003, 163, 1448-1453.
32. Judd, J. T.; Davies, M. J.; Baer, D. J.; Chan, S. C.; Wiseman, S.; Agarwal, S. Black tea consumption reduces total and LDL cholesterol in mildly hypercholesterolemic subjects. J. Nutr. 2003, 133, 3298S-3302S.
33. Mukumal, K. J.; Maclure, M.; Muller, J. E.; Sherwood, J. B.; Mittleman, M. A. Tea consumption and mortality after acute myocardial infarction. Circulation 2002, 105, 2476-2481.